SARS-CoV-2 - Secondary antibodies for research and development

SARS-CoV-2 - Secondary antibodies for research and development


The current COVID-19 pandemic has sickened more than 520,000 people worldwide and continues to increase daily. There is an urgent need to increase current diagnostic capacity. Compared to the commonly used PCR test, the diagnostic method based on the serological test is much easier and faster to perform. To support the development of immunodiagnostic methods, we offer a comprehensive collection of antibodies and antigens for SARS-CoV-2.
We offer a full range of antibodies to human IgG and IgM for research and development of kits for the detection of anti-SARS-CoV-2 antibodies in patient samples.
Rapid tests for the screening of COVID-19 affected patients, based on the principle of immunochromatography, use anti-human IgG and IgM antibodies to detect anti-SARS-CoV-2 antibodies produced by patients in serum, plasma or whole blood samples.

Cat#
Description
Size
Price Excl. VAT
BT52-1900-04
 500 ug 
BT52-7537-09
 1 ml 
BTOB-T509-4
 500 ug 
Rabbit Monoclonal Anti-Human IgG (Clone: E20-V)
DB173-RTU-1
 1ml,prediluted 
Rabbit Monoclonal Anti-Human IgG (Clone: I17-T)
DB174-RTU-1
 1ml,prediluted 
Number of results per page : 10 50 250